Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study
Health Technology Assessment · 2026-02 · 1-72
DOI: 10.3310/thsn9956 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Health Technology Assessment, 2026-02. Verfasst von Shankar Kumar und 42 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Imaging, University College London, London, UK. Hauptthemen laut MEDLINE: Crohn Disease, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.
Abstract (Originalsprache)
Background
The ability to predict whether patients with a new diagnosis of Crohn’s disease will develop disabling disease is an unmet clinical need. Magnetic resonance enterography is a first-line investigation for Crohn’s disease, but its role in prognostication is unknown. Objective(s) To improve prediction of disabling Crohn’s disease within 5 years of diagnosis by developing and internally evaluating a multivariable prediction model comprising clinical predictors and adding magnetic resonance enterography scores (Magnetic resonance Enterography Global Score, Simplified Magnetic Resonance Index of Activity and Lémann Index). To estimate the healthcare costs incurred within 5 years of Crohn’s disease diagnosis and to explore factors driving costs.
Design
A multicentre diagnostic inception cohort.
Setting
Nine National Health Service hospitals.
Participants
Aged ≥ 16 years with newly diagnosed Crohn’s disease. Main outcome measures Comparative predictive ability of prognostic models, including magnetic resonance enterography scores (Magnetic resonance Enterography Global Score, Simplified Magnetic Resonance Index of Activity and Lémann Index) versus a model based on clinical predictors alone for the development of modified Beaugerie disabling Crohn’s disease within 5 years of diagnosis. Statistical analysis We censored development of modified Beaugerie disabling disease ≤ 90 days from diagnosis, and utilised time-to-event models using Royston–Parmar flexible parametric models. Risk group definitions were prespecified; for risk group definition 1, the high-risk patients were the top 40% with the greatest predicted risk, and the high-risk patients had an absolute risk ≥ 10% for risk group definition 2. The absolute risk cut-off was calculated by sorting patients by predicted risk and using the risk of the eighth (10% of 81) patient who developed modified Beaugerie disabling disease.
Results
We studied 194 patients, median age 29, interquartile range 22–44 years. Within 5 years from diagnosis, 42% (81/194) developed modified Beaugerie disabling disease. There was a univariable association between initial need for steroid therapy and developing modified Beaugerie disabling disease [hazard ratio 2.11 (95% confidence interval 1.36 to 3.26)]. Using risk group definition 1, the baseline clinical model had 49% (95% confidence interval 39 to 60) sensitivity and 66% (95% confidence interval 57 to 74) specificity for predicting the development of modified Beaugerie disabling disease. There was no difference in sensitivity and specificity between models incorporating Magnetic resonance Enterography Global Score, Simplified Magnetic Resonance Index of Activity and Lémann Index compared to the baseline clinical model. Using risk group definition 2, the model, including magnetic resonance enterography predictors, had 86% (95% confidence interval 77 to 92) sensitivity and 35% (95% confidence interval 27 to 45) specificity for predicting the development of modified Beaugerie disabling disease. There was no difference in sensitivity between the clinical model and models incorporating Magnetic resonance Enterography Global Score, Simplified Magnetic Resonance Index of Activity and Lémann Index, but specificity was significantly lower for models incorporating Magnetic resonance Enterography Global Score [29% (95% confidence interval 22 to 38)] and Lémann Index [29% (95% confidence interval 22 to 38)]. The mean total 5-year per-patient cost of health care was £24,267 (standard deviation £33,108). Mean 5-year costs were £29,763 (standard deviation £38,278) compared to £20,327 (standard deviation £28,368) for those with and without disabling disease, respectively. The largest contributor to costs was biologic use. Age under 40 years, presence of perianal disease and presence of severe endoscopic disease were associated with higher costs.
Limitations
Liège and Montreal criteria for disabling disease could not be studied due to an insufficient event rate.
Conclusions
Addition of magnetic resonance enterography scores to a multivariable model comprising existing clinical predictors did not improve prediction of modified Beaugerie disabling disease. Healthcare costs were increased in those aged under 40 years and patients with perianal and severe endoscopic disease. Future work Testing the predictive ability of magnetic resonance enterography against alternative definitions for disabling Crohn’s disease.
Trial registration
This trial is registered as ISRCTN76899103. Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 15/59/17) and is published in full in Health Technology Assessment ; Vol. 30, No. 18. See the NIHR Funding and Awards website for further award information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Medical Imaging, University College London, London, UK.
- Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
- The Research Department of Primary Care and Population Health, University College London, London, UK.
- Department of Radiology, Frimley Health NHS Foundation Trust, Frimley Park Hospital, Surrey, UK.
- Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Gastroenterology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
ORCID-Profile: Shankar Kumar, Andrew Plumb, Sue Mallett, Caroline Clarke, Tom Parry, Jing Yi Jessica Weng, Gauraang Bhatnagar, Stuart Bloom, John Hamlin, Ailsa Hart, Simon Travis, Roser Vega, Maira Hameed, Anisha Bhagwanani, Rebecca Greenhalgh, Emma Helbren, James A Stephenson, Ian Zealley, Vivienne Eze, James Franklin, Alison Corr, Arun Gupta, Elizabeth Isaac, Damian Tolan, William Hogg, Antony Higginson, Michela Cicchetti, Sunita Gupta, Miguel Serran, Tim Raine, Mohamed Ahmed, Biljana Brezina, Ilse Patterson, Louise Lee, Richard Pollok, Jaymin Patel, Abigail Seward, Samantha Baillie, Kashfia Chowdary, Sue Philpott, Anvi Wadke, Steve Halligan, Stuart A Taylor
Förderung
- Health Technology Assessment programme
Zitieren
APA
Kumar, S., Plumb, A., Mallett, S., Clarke, C., Parry, T., Weng, J. Y. J., Bhatnagar, G., Bloom, S., Hamlin, J., Hart, A., Travis, S., Vega, R., Hameed, M., Bhagwanani, A., Greenhalgh, R., Helbren, E., Stephenson, J. A., Zealley, I., Eze, V., …, & Taylor, S. A. (2026). Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study. Health Technology Assessment, 1-72. https://doi.org/10.3310/thsn9956
Vancouver
Kumar S, Plumb A, Mallett S, Clarke C, Parry T, Weng JYJ, et al. Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study. Health Technology Assessment. 2026:1-72. doi:10.3310/thsn9956
BibTeX
@article{Kumar2026,
author = {Kumar, Shankar and Plumb, Andrew and Mallett, Sue and Clarke, Caroline and Parry, Tom and Weng, Jing Yi Jessica and Bhatnagar, Gauraang and Bloom, Stuart and Hamlin, John and Hart, Ailsa and Travis, Simon and Vega, Roser and Hameed, Maira and Bhagwanani, Anisha and Greenhalgh, Rebecca and Helbren, Emma and Stephenson, James A and Zealley, Ian and Eze, Vivienne and Franklin, James and Corr, Alison and Gupta, Arun and Isaac, Elizabeth and Tolan, Damian and Hogg, William and Higginson, Antony and Cicchetti, Michela and Gupta, Sunita and Serran, Miguel and Raine, Tim and Ahmed, Mohamed and Brezina, Biljana and Patterson, Ilse and Lee, Louise and Pollok, Richard and Patel, Jaymin and Seward, Abigail and Baillie, Samantha and Chowdary, Kashfia and Philpott, Sue and Wadke, Anvi and Halligan, Steve and Taylor, Stuart A},
title = {Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study},
journal = {Health Technology Assessment},
year = {2026},
pages = {1--72},
doi = {10.3310/thsn9956}
}
EUVIMED